Disease-Modifying Drugs Reduce Cortical Lesion Accumulation and Atrophy Progression in Relapsing-Remitting Multiple Sclerosis: Results from a 48-Month Extension Study
Rinaldi et al.
Multiple Sclerosis International; February
The following content is accessible for members only, please sign in.
Loading…